Evidence map›Paper›PMID 34453571›Full record

Observational studyEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2022

Clinical implications of alpha, beta, and gamma HPV infection in juvenile onset recurrent respiratory papillomatosis.

Martina Bertinazzi, Tarik Gheit, Jerry Polesel, Sandrine McKay-Chopin, Cesare Cutrone, Marianna Sari, Marta Sbaraglia, Angelo Paolo Dei Tos, Piero Nicolai, Massimo Tommasino and 1 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. HPV-related diseases in male patients: an underestimated conundrum.Journal of endocrinological investigation · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Martina BertinazziDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Padova, Italy.
Tarik GheitInternational Agency for Research On Cancer, Lyon, France.
Jerry PoleselUnit of Cancer Epidemiology, Centro Di Riferimento Oncologico Di Aviano (CRO) IRCCS, Aviano, Italy.
Sandrine McKay-ChopinInternational Agency for Research On Cancer, Lyon, France.
Cesare CutroneDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Padova, Italy.
Marianna SariDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Padova, Italy.
Marta SbaragliaDepartment of Medicine, Section of Pathology, University of Padova, Padova, Italy.
Angelo Paolo Dei TosDepartment of Medicine, Section of Pathology, University of Padova, Padova, Italy.
Piero NicolaiDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Padova, Italy.
Massimo TommasinoInternational Agency for Research On Cancer, Lyon, France.
Paolo Boscolo-RizzoDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Padova, Italy. paolo.boscolorizzo@units.it.ORCID http://orcid.org/0000-0002-4635-7959
University of Padua · ITCentre international de recherche sur le cancer · FRCentro di Riferimento Oncologico · IT

Funding

World Health Organization 001
6 · The paper itself

Abstract

purposeThe aim of our study was to evaluate the prevalence of different HPV genera-alpha, beta and gamma-in Juvenile onset Recurrent Respiratory Papillomatosis (JoRRP) and examine the association of type and genus-specific viral features with the clinical outcome of disease.

methodsThis retrospective observational study included consecutive patients with JoRRP who were treated in a referral centre between October 2000 and October 2020. All patients underwent cold excision and laser vaporisation of papillomatous lesions. Samples were analysed for the presence of 120 viral genotypes (22 alpha-HPV, 46 beta-HPV, 52 gamma-HPV) using a highly sensitive multiplex genotyping assay.

resultsTwenty patients with JoRRP, aged 0.3-11 years, were included, with a median follow-up of 13.5 years. All samples were HPV DNA positive: 20 (100%) for alpha-HPV DNA; 7 (35%) for beta-HPV DNA; 0 for gamma-HPV DNA. Three groups were defined according to the number of infections: seven cases (35%) with HPV mono-infection; ten cases (50%) with HPV double-infection; three cases (15%) with ≥ 3 HPV infections. At diagnosis, patients with ≥ 3 HPV infections reported higher median Derkay's score than those with mono-infection (21 vs 14, P = 0.018). Number of HPV infections was also associated with clinical outcomes, with an average of 0.5 surgical procedures/year in patients with mono-infection, 1.2 for double-infection, 2.6 for ≥ 3 infections (P = 0.006).

conclusionDespite the small sample size, these preliminary data support an association between the number of different alpha and beta HPV co-infections and the clinical severity of the disease.

Indexed as

Papillomavirus InfectionsRespiratory Tract InfectionsAdolescentChildChild, PreschoolGenotypeHumansInfantYoung AdultChildrenCo-infectionsHuman papillomavirusJuvenile respiratory papillomatosisPrognosis

Identifiers

PMID34453571
PMCPMC8738360
OpenAlexW3193868196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.